Michael Weichenthal

19.7k total citations · 3 hit papers
137 papers, 6.2k citations indexed

About

Michael Weichenthal is a scholar working on Oncology, Dermatology and Molecular Biology. According to data from OpenAlex, Michael Weichenthal has authored 137 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 51 papers in Dermatology and 39 papers in Molecular Biology. Recurrent topics in Michael Weichenthal's work include Cutaneous Melanoma Detection and Management (41 papers), CAR-T cell therapy research (24 papers) and Melanoma and MAPK Pathways (20 papers). Michael Weichenthal is often cited by papers focused on Cutaneous Melanoma Detection and Management (41 papers), CAR-T cell therapy research (24 papers) and Melanoma and MAPK Pathways (20 papers). Michael Weichenthal collaborates with scholars based in Germany, United States and Switzerland. Michael Weichenthal's co-authors include Enno Christophers, Stefan Jenisch, Jan Wehkamp, Eduard F. Stange, Klaus Fellermann, Axel Hauschild, M Suchán, Matthias Schwab, Charles Bevins and Thomas Schwarz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Weichenthal

136 papers receiving 6.0k citations

Hit Papers

Reduced Paneth cell α-defensins in ileal Crohn's disease 2004 2026 2011 2018 2005 2004 2006 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reduced Paneth cell α-defensins in ileal Crohn's disease
    2005 749 citations Jan Wehkamp, Nita H. Salzman et al. Proceedings of the National Academy of Sciences profile →
  2. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
    2004 618 citations Jan Wehkamp, Jürgen Harder et al. profile →
  3. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis
    2006 526 citations Enno Christophers, Michael Weichenthal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Weichenthal Germany 37 2.5k 1.8k 1.6k 1.5k 855 137 6.2k
Alexander A. Navarini Switzerland 41 3.5k 1.4× 761 0.4× 2.5k 1.5× 646 0.4× 854 1.0× 252 7.0k
Annamari Ranki Finland 47 3.4k 1.4× 1.3k 0.7× 3.3k 2.0× 902 0.6× 571 0.7× 226 8.8k
Robin E. Callard United Kingdom 45 3.9k 1.5× 1.2k 0.7× 417 0.3× 760 0.5× 354 0.4× 134 6.5k
Klaus Wolff Austria 57 4.2k 1.7× 2.9k 1.6× 3.1k 1.9× 2.6k 1.8× 522 0.6× 182 11.8k
Harald Gollnick Germany 56 1.6k 0.6× 2.1k 1.2× 5.7k 3.5× 919 0.6× 265 0.3× 291 9.8k
Arian Laurence United States 50 10.1k 4.0× 2.7k 1.5× 1.1k 0.7× 3.9k 2.7× 992 1.2× 98 15.0k
Annamaria Offidani Italy 36 1.2k 0.5× 929 0.5× 1.2k 0.8× 591 0.4× 173 0.2× 227 4.2k
Michael W. Leach United States 33 6.4k 2.6× 1.4k 0.8× 368 0.2× 1.5k 1.0× 2.0k 2.4× 72 9.4k
Xin Chen China 49 3.9k 1.6× 3.4k 1.9× 277 0.2× 1.4k 1.0× 426 0.5× 244 9.6k
Sergio Chimenti Italy 40 4.0k 1.6× 1.0k 0.6× 3.4k 2.1× 1.5k 1.0× 435 0.5× 187 7.2k

Countries citing papers authored by Michael Weichenthal

Since Specialization
Citations

This map shows the geographic impact of Michael Weichenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Weichenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Weichenthal more than expected).

Fields of papers citing papers by Michael Weichenthal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Weichenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Weichenthal. The network helps show where Michael Weichenthal may publish in the future.

Co-authorship network of co-authors of Michael Weichenthal

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Weichenthal. A scholar is included among the top collaborators of Michael Weichenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Weichenthal. Michael Weichenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bohne, Ann‐Sophie, et al.. (2024). Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medications. Acta Dermato Venereologica. 104. adv35215–adv35215. 1 indexed citations
2.
Heidrich, Isabel, Daniel J. Smit, Michael Weichenthal, et al.. (2024). C‐reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma. Journal of the European Academy of Dermatology and Venereology. 38(8). 1575–1587. 4 indexed citations
3.
Weichenthal, Michael, Inge Marie Svane, Johanna Mangana, et al.. (2024). Real-World efficiency of pembrolizumab in metastatic melanoma patients following adjuvant anti-PD1 treatment. SHILAP Revista de lepidopterología. 2. 100271–100271. 1 indexed citations
4.
Serra-Bellver, Patricio, Joy Conway, Matteo S. Carlino, et al.. (2023). 1106P Anti-PD-1 (PD1) monotherapy or in combination with anti-CTLA-4 for metastatic melanoma (MM) patients (pts) with liver metastases (mets). Annals of Oncology. 34. S666–S667. 2 indexed citations
5.
Zimmer, Lisa, Selma Ugurel, Friedegund Meier, et al.. (2023). Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma – An analysis of the prospective skin cancer registry ADOREG. European Journal of Cancer. 198. 113508–113508. 2 indexed citations
6.
Kimmig, Martin, Klaus Griewank, Eva Hadaschik, et al.. (2023). 1168P Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examined. Annals of Oncology. 34. S695–S695. 1 indexed citations
7.
Kaatz, Martin, Peter Möhr, Elisabeth Livingstone, et al.. (2022). Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONAS. Acta Dermato Venereologica. 102. adv00695–adv00695. 4 indexed citations
8.
Schmitt, Max, Roman C. Maron, Achim Hekler, et al.. (2021). Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study. Journal of Medical Internet Research. 23(2). e23436–e23436. 40 indexed citations
9.
Maron, Roman C., Jochen Utikal, Achim Hekler, et al.. (2020). Artificial Intelligence and Its Effect on Dermatologists’ Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study. Journal of Medical Internet Research. 22(9). e18091–e18091. 47 indexed citations
10.
McArthur, Grant A., Peter Mohr, Paolo A. Ascierto, et al.. (2017). Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study). The Oncologist. 22(8). 951–962. 14 indexed citations
11.
Leiter, Ulrike, Michael Weichenthal, Annette Pflugfelder, et al.. (2013). Diagnosis and Follow-up of Melanoma - what will change with the new S3 Guideline?. Queensland's institutional digital repository (The University of Queensland). 11. 56–56. 1 indexed citations
12.
Dummer, Reinhard, Pietro Quaglino, Jürgen C. Becker, et al.. (2012). Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012. Journal of Clinical Oncology. 30(33). 4091–4097. 70 indexed citations
13.
Jantschitsch, Christian, Michael Weichenthal, Ehrhardt Proksch, Thomas Schwarz, & Agatha Schwarz. (2012). IL-12 and IL-23 Affect Photocarcinogenesis Differently. Journal of Investigative Dermatology. 132(5). 1479–1486. 16 indexed citations
14.
Meier, Markus K, et al.. (2011). Glucocorticosteroid‐resistant pemphigoid gestationis: Successful treatment with adjuvant immunoadsorption. The Journal of Dermatology. 39(2). 168–171. 19 indexed citations
15.
Ding, Jun, Jóhann E. Guðjónsson, Liming Liang, et al.. (2010). Gene Expression in Skin and Lymphoblastoid Cells: Refined Statistical Method Reveals Extensive Overlap in cis-eQTL Signals. The American Journal of Human Genetics. 87(6). 779–789. 127 indexed citations
16.
Weichenthal, Michael, et al.. (2006). Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. Journal of Cancer Research and Clinical Oncology. 133(4). 253–261. 63 indexed citations
17.
Fölster‐Holst, Regina, et al.. (2006). Low prevalence of the intrinsic form of atopic dermatitis among adult patients. Allergy. 61(5). 629–632. 51 indexed citations
18.
Wehkamp, Jan, Nita H. Salzman, Edith Porter, et al.. (2005). Reduced Paneth cell α-defensins in ileal Crohn's disease. Proceedings of the National Academy of Sciences. 102(50). 18129–18134. 749 indexed citations breakdown →
19.
Kowalzick, L., Andreas Kleinheinz, Michael Weichenthal, et al.. (1994). Effects of medium-dose UV-A1 on clinical course and serum levels of sICAM-1, sELAM-1, sIL-2R and ECP in severe atopic eczema. Journal of Investigative Dermatology. 103(3). 410. 1 indexed citations
20.
Ehlert, Ulrike, et al.. (1992). Fibroblast cultures of patients with basal cell epithelioma exhibit a normal sensitivity to the genotoxic effect of ultraviolet irradiation. Cancer Genetics and Cytogenetics. 61(1). 74–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander A. Navarini Breakdown of academic impact, for papers by Annamari Ranki Breakdown of academic impact, for papers by Robin E. Callard Breakdown of academic impact, for papers by Klaus Wolff Breakdown of academic impact, for papers by Harald Gollnick Breakdown of academic impact, for papers by Arian Laurence Breakdown of academic impact, for papers by Annamaria Offidani Breakdown of academic impact, for papers by Michael W. Leach Breakdown of academic impact, for papers by Xin Chen Breakdown of academic impact, for papers by Sergio Chimenti
Rankless by CCL
2026